These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model. Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026 [TBL] [Abstract][Full Text] [Related]
7. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease. Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651 [TBL] [Abstract][Full Text] [Related]
8. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
9. Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-Synuclein. Schidlitzki A; Stanojlovic M; Fournier C; Käufer C; Feja M; Gericke B; Garzotti M; Welford RWD; Steiner MA; Angot E; Richter F Mov Disord; 2023 Jun; 38(6):1044-1055. PubMed ID: 37050861 [TBL] [Abstract][Full Text] [Related]
11. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain. Zhang J; Zhao M; Yan R; Liu J; Maddila S; Junn E; Mouradian MM Neurotherapeutics; 2021 Oct; 18(4):2529-2540. PubMed ID: 34697773 [TBL] [Abstract][Full Text] [Related]
14. Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease. Arawaka S; Fukushima S; Sato H; Sasaki A; Koga K; Koyama S; Kato T PLoS One; 2014; 9(2):e89076. PubMed ID: 24586512 [TBL] [Abstract][Full Text] [Related]
15. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model. Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain. Svarcbahs R; Julku UH; Myöhänen TT J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease. Zhang LF; Yu XL; Ji M; Liu SY; Wu XL; Wang YJ; Liu RT Food Funct; 2018 Dec; 9(12):6414-6426. PubMed ID: 30462117 [TBL] [Abstract][Full Text] [Related]
18. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia. Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690 [TBL] [Abstract][Full Text] [Related]